Search for Clinical Trial Results

Sponsored By

Polyomavirus Infections - 25 Studies Found

Status Study
Completed Study Name: Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Condition: Polyomavirus Infections
Date: 2005-09-08
Interventions:
  • Drug: Ciclosporin and Mycophenolate-mofetil

Recruiting Study Name: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Condition:
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcino
    Date: 2015-10-21
    Interventions:
    • Drug: Avelumab Given IV

Recruiting Study Name: Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis.
Condition:
  • Polyoma Virus Infection
  • Thyroiditis, Autoimmune

Date: 2017-03-31
Interventions: Other: Comparison of Positive PCR Frequencies for Polyomavirus in Blood, Urine and / or Thyroid Tissue vs Basedow / Hashimoto
Completed Study Name: Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study
Condition:
  • Disease Due to BK Polyomavirus
  • Kidney Transplant Infection

Date: 2011-05-11
Interventions: Drug: Levofloxacin 500mg, PO, once daily for 3 months
Recruiting Study Name: Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Condition:
  • Dermatologic Conditions
  • Healthy Volunteers
  • Normal Voluntee
    Date: 2015-06-12
Available Study Name: Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
Condition: Metastatic Merkel Cell Carcinoma
Date: 2017-03-20
Interventions: Drug: Avelumab Avelumab should be administered intravenously as per the recommended dose. Administration
Recruiting Study Name: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Date: 2015-07-28
Interventions: Drug: MLN0128 Investigational mTOR kinase inhibitor
Recruiting Study Name: QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Condition:
  • Stage IIIB Merkel Cell Carcinoma
  • Stage IV Merkel Cell Carcinoma

Date: 2015-06-03
Interventions: Biological: aNK (NK-92) A natural killer cell line recovered from a patient with large granular lymphoma
Recruiting Study Name: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues
Condition: Carcinoma, Merkel Cell
Date: 2015-01-13
Interventions: Drug: Lanreotide Other Name: Somatuline
Active, not recruiting Study Name: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Condition:
  • Recurrent Merkel Cell Carcinoma
  • Stage IIIA Merkel Cell Carcinoma
  • Other: Laboratory Biomarker Analysis

Next >>>